PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Juxiang Zang

Jinling Institute of Technology

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · JOURNAL ARTICLE

Response of HER2 positive gallbladder adenocarcinoma to trastuzumab emtansine (T-DM1): a case report and literature review

Frontiers in Oncology

A single case report with a favorable outcome in HER2-positive gallbladder cancer treated with trastuzumab emtansine; raises a hypothesis for future investigation but lacks comparative design, control, or replication.

PreliminaryCholangiocarcinoma and Gallbladder Cancer Studies Juxiang Zang Wei Ling

Reported

Disease-free survival13 months

Cycles of trastuzumab emtansine b…2

Patient age46 years

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support